Lava Therapeutics NV Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Gilde Healthcare has reduced its beneficial ownership in LAVA Therapeutics N.V. to 3.9% after selling over 1.9 million common shares.
Gilde Healthcare has significantly reduced its beneficial ownership in LAVA Therapeutics N.V. by selling over 2.2 million common shares in open market transactions.
Gilde Healthcare, a significant shareholder, has sold 174,678 common shares of LAVA Therapeutics N.V. in open market transactions, reducing its beneficial ownership to 19.9%.
Versant Venture Capital and related entities have fully divested their stake in LAVA Therapeutics N.V., selling over 2.9 million shares for approximately $4.07 million.
Versant Venture Capital and Vantage funds have significantly reduced their beneficial ownership in LAVA Therapeutics N.V. through recent share sales totaling over $2.5 million.